APT Historical Cash Flow
| 688617 Stock | 390.00 3.00 0.76% |
Analysis of APT Medical cash flow over time is an excellent tool to project APT Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 1.2 B or Free Cash Flow of 588.1 M as it is a great indicator of APT Medical ability to facilitate future growth, repay debt on time or pay out dividends.
APT |
About APT Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in APT balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which APT's non-liquid assets can be easily converted into cash.
APT Medical Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by APT Medical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of APT Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in APT Medical financial statement analysis. It represents the amount of money remaining after all of APT Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from APT Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into APT Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in APT Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, APT Medical's Change To Inventory is projected to decrease significantly based on the last few years of reporting. The current year's Change In Cash is expected to grow to about 1.2 B, whereas Begin Period Cash Flow is forecasted to decline to about 159 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 143.2M | 202.0M | 232.3M | 244.0M | Dividends Paid | 69.0M | 112.2M | 129.1M | 135.5M |
APT Medical cash flow statement Correlations
Click cells to compare fundamentals
APT Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
APT Medical cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (2.4M) | (124.2M) | (72.6M) | 11.2M | 10.1M | 10.6M | |
| Change In Cash | 46.8M | 189.3M | (60.7M) | 1.0B | 1.2B | 1.2B | |
| Free Cash Flow | 104.0M | 14.0M | 224.3M | 487.0M | 560.1M | 588.1M | |
| Change In Working Capital | 22.1M | (45.6M) | (33.1M) | 95.2M | 109.5M | 115.0M | |
| Begin Period Cash Flow | 73.5M | 120.3M | 309.7M | 249.0M | 286.3M | 159.0M | |
| Other Cashflows From Financing Activities | 15.9M | 15.0M | 1.2B | (149.7M) | (172.2M) | (163.6M) | |
| Depreciation | 20.0M | 33.4M | 48.3M | 64.8M | 74.6M | 78.3M | |
| Other Non Cash Items | 1.9M | (1.3M) | 12.1M | 4.1M | 4.7M | 3.4M | |
| Dividends Paid | 1.4M | 33.2M | 69.0M | 112.2M | 129.1M | 135.5M | |
| Capital Expenditures | 44.2M | 167.4M | 143.2M | 202.0M | 232.3M | 244.0M | |
| Total Cash From Operating Activities | 148.2M | 181.4M | 367.5M | 689.1M | 792.4M | 832.0M | |
| Net Income | 104.2M | 194.9M | 340.2M | 535.6M | 616.0M | 646.8M | |
| Total Cash From Financing Activities | (3.2M) | (101.6M) | 1.1B | (294.6M) | (338.8M) | (321.8M) | |
| End Period Cash Flow | 120.3M | 309.7M | 249.0M | 1.3B | 1.5B | 1.5B | |
| Investments | 730.1K | (1.1B) | (134.5M) | 581.9M | 669.2M | 702.6M |
Currently Active Assets on Macroaxis
Other Information on Investing in APT Stock
The Cash Flow Statement is a financial statement that shows how changes in APT balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which APT's non-liquid assets can be easily converted into cash.